Literature DB >> 6147603

Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin.

C M Gosden, J R Gosden.   

Abstract

Ultrastructural and microvillous enzyme (MVE) histochemical studies of fetuses with cystic fibrosis (CF) and trisomies 13 and 18 identified features in CF which differed from the abnormalities in trisomies 13 and 18. The principal abnormalities in CF were in the tight (occluding) junctions and intracellular organelles, particularly the golgi and mitochondria, of the epithelial cells of the pancreas, respiratory system, intestine, and gallbladder. Abnormalities of amniotic fluid MVE levels in CF and trisomy 13 occur because of disruption of the pathways by which the MVE reach the amniotic fluid. Trisomy 18 shows hypoplasia and deficiency of epithelial cell microvilli. It is postulated that the basic defect in CF is due to the deficiency of an enzyme that cleaves the Arg-Asp peptide bond in cholecystokinin to produce the active octapeptide CCK-8, which normally stimulates exocrine secretion, especially in pancreas, gallbladder, and intestine, and potentiates the action of other gastrointestinal hormones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147603     DOI: 10.1016/s0140-6736(84)90765-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  False positive results with immunoreactive trypsinogen screening for cystic fibrosis owing to trisomy 13.

Authors:  F J Priest; N C Nevin
Journal:  J Med Genet       Date:  1991-08       Impact factor: 6.318

Review 2.  Small-intestinal abnormalities in cystic fibrosis patients.

Authors:  E Eggermont; K De Boeck
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

3.  Small intestinal permeability and orocaecal transit time in cystic fibrosis.

Authors:  A M Dalzell; N S Freestone; D Billington; D P Heaf
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

Review 4.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

5.  Chloride channels regulate differentiation and barrier functions of the mammalian airway.

Authors:  Mu He; Bing Wu; Wenlei Ye; Daniel D Le; Adriane W Sinclair; Valeria Padovano; Yuzhang Chen; Ke-Xin Li; Rene Sit; Michelle Tan; Michael J Caplan; Norma Neff; Yuh Nung Jan; Spyros Darmanis; Lily Yeh Jan
Journal:  Elife       Date:  2020-04-14       Impact factor: 8.140

6.  Sucrase-isomaltase and cystic fibrosis.

Authors:  H J Sips; A H Claass; J M van Dongen; R Willemsen; A T Hoogeveen; H Galjaard; M Sinaasappel; H P Hauri; E E Sterchi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

7.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

8.  Evidence for a Cystic Fibrosis Enteropathy.

Authors:  Marlou P M Adriaanse; Linda J T M van der Sande; Anita M van den Neucker; Paul P C A Menheere; Edward Dompeling; Wim A Buurman; Anita C E Vreugdenhil
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

Review 9.  Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.

Authors:  Virginia De Rose; Kevin Molloy; Sophie Gohy; Charles Pilette; Catherine M Greene
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

Review 10.  What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?

Authors:  Margarida D Amaral; Margarida C Quaresma; Ines Pankonien
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.